Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain - a podcast by Clinical Care Options

from 2022-05-04T05:02:28.920611

:: ::

In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer. 

Presenters:

Félix Guerrero Ramos, MD, PhD, FEBU 
Teaching Collaborator
Department of Surgery
Medicine School
Universidad Complutense de Madrid
Attending Urologist
Department of Urology
UroOncology Unit
Madrid, Spain 

Óscar Rodríguez-Faba, MD 
Urologist
Uro-Oncology
Fundació Puigvert
Barcelona, Catalonia, Spain

Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.

Link to full program, including associated downloadable slidesets and on-demand Webcast:
http://bit.ly/3kJC5SL

Further episodes of CCO Oncology Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options